Xuyan Ru is a Research Scientist specializing in Model-Driven Drug Discovery at Eli Lilly and Company, where they support the MD3 Platform. They earned a Ph.D. in Computational Chemistry from Duke University and have extensive experience in cheminformatics and molecular design. Previously, Xuyan worked as a Postdoctoral Research Scientist, where they developed a model-driven drug design platform and optimized molecular properties through deep learning. They began their academic journey with a Bachelor's Degree in Pharmacy from Nankai University, followed by a Graduate Research Assistant role at Duke University.
This person is not in any teams
This person is not in any offices